CORRIE HANSEN: Open Payments
NPI 1689284820 · WILSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 81 payments from 13 companies in 2025. Trend: 2023 $931 · 2024 $794 · 2025 $1,369
Food & beverage: $1,369
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $433 |
| Novo Nordisk Inc | 12 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $164 |
| Corcept Therapeutics | 7 | $154 |
| Viatris Specialty LLC | 4 | $61 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Amgen Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: VRAYLAR, CAPLYTA, Korlym, UBRELVY, Wegovy, FARXIGA, QULIPTA, YUPELRI.
Industry payments across NC — which companies pay providers there.
